Back to search
FDAFDA · Food and drugs·Recall number D-0452-2020

OCuSOFT retaine NaCl Sodium Chloride Hypertonicity Opthalmic Ointment, Net. wt. 1/8 oz (3.5 g), Sterile, Distributed by OCuSOFT, Inc. Rosenberg, TX 77471 USA

Published November 27, 2019 · Recall initiated: July 2, 2019

Summary

FDA records drug Class II recall D-0452-2020, published November 27, 2019 and initiated July 2, 2019. Recalling firm: Altaire Pharmaceuticals, Inc.; Status: Completed; Reported quantity: 19632 units; Lot: Lot #: SAP 1/20 SFI 6/20 TCI 3/21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Altaire Pharmaceuticals, Inc.
Distributor
U.S.A. Nationwide
Lot
Lot #: SAP 1/20 SFI 6/20 TCI 3/21
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was OCuSOFT retaine NaCl Sodium Chloride Hypertonicity Opthalmic Ointment, Net. wt. 1/8 oz (3.5 g), Sterile, Distributed by OCuSOFT, Inc. Rosenberg, TX 77471 USA recalled?

Yes. FDA published recall D-0452-2020 on November 27, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit